Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of treating cancer with a combination of an anti-CCR4 antibody and a 4-1BB agonist

US Patent 10023649 · Granted Jul 17, 2018

Estimated economic value: $209,955,000

Assignee

Inventors

View full patent text on Google Patents →